Label Changes for:

Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol

September 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

September 2013

ADVERSE REACTIONS

Postmarketing Adverse Reactions
  • added ... dysphonia and gastroesophageal reflux disease
     

 

Hide
(web5)